News In Brief

LIVE TALK sessions are now available on Demand.  Click here to listen to past shows.

From Recordati Rare Diseases Phase III study confirms the efficacy and safety of   ISTURISA®.  achieving sustained cortisol control in the majority of patients. Read more

Good news from Amryt Pharma for acromegaly patients in Europe.  Read the release from Amryt Pharma on Mycapssa® here.

Corcept Therapeutics announces new communication materials for Phase 3 Trial of Relacolirant in patients with Cushing’s syndrome.  Click here to learn more and see if you qualify. 

Crinetics Pharmaceuticals moves forward with Paltusotine® phase 3 study.  To learn more about the trial and see if you qualify Read more here

Read more about clinical trials from  Xeris Pharma, Camurus AB, and  Ionis Ph

The Podcast

Knowledge and information are critical tools to affect early diagnosis in pituitary disease. Join Dr. Lewis Blevins and Jorge D Faccinetti cofounders, as they navigate the wonders and complexities of pituitary conditions.

A highly informational "live-talk" session from Dr. Blevins.  The first segment covers the indications for pituitary surgery for patients with pituitary adenomas.  In the second half of the program, he discusses critical information for patients with Central Adrenal Insufficiency due to hypothalamic or pituitary disease.  

In session three, we cover the many possible complications from pituitary surgery in terms of pituitary function and the anatomy around the gland. This is a comprehensive review of potential consequences that all pituitary patients, whether they have had, or are about to have surgery, should know and discuss with their surgeons.